PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.87%
Revenue growth above 1.5x AVGO's 1.38%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
24.33%
Gross profit growth above 1.5x AVGO's 3.98%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
62.35%
EBIT growth above 1.5x AVGO's 31.59%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
62.35%
Operating income growth above 1.5x AVGO's 31.59%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
62.86%
Net income growth above 1.5x AVGO's 22.20%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
60.87%
EPS growth above 1.5x AVGO's 25.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
56.52%
Diluted EPS growth above 1.5x AVGO's 16.67%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.16%
Share reduction more than 1.5x AVGO's 0.50%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.32%
Diluted share reduction more than 1.5x AVGO's 1.20%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-1.18%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
75.21%
Positive OCF growth while AVGO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
86.76%
FCF growth above 1.5x AVGO's 0.26%. David Dodd would verify if the firm’s strategic investments yield superior returns.
201.58%
10Y revenue/share CAGR under 50% of AVGO's 527.66%. Michael Burry would suspect a lasting competitive disadvantage.
120.88%
5Y revenue/share CAGR similar to AVGO's 120.62%. Walter Schloss might see both companies benefiting from the same mid-term trends.
32.65%
3Y revenue/share CAGR similar to AVGO's 31.72%. Walter Schloss would assume both companies experience comparable short-term cycles.
948.80%
10Y OCF/share CAGR at 50-75% of AVGO's 1275.71%. Martin Whitman might fear a structural deficiency in operational efficiency.
583.02%
5Y OCF/share CAGR above 1.5x AVGO's 253.00%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
215.81%
3Y OCF/share CAGR above 1.5x AVGO's 93.81%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
655.24%
Net income/share CAGR above 1.5x AVGO's 231.72% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
366.75%
5Y net income/share CAGR above 1.5x AVGO's 88.50%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
46.29%
3Y net income/share CAGR similar to AVGO's 44.46%. Walter Schloss would attribute it to shared growth factors or demand patterns.
318.16%
Below 50% of AVGO's 949.30%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
139.51%
5Y equity/share CAGR at 50-75% of AVGO's 262.27%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
85.77%
3Y equity/share CAGR above 1.5x AVGO's 20.29%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
89.07%
Below 50% of AVGO's 776.34%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
40.25%
Below 50% of AVGO's 279.34%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-6.79%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-13.04%
Inventory is declining while AVGO stands at 13.43%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
7.01%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
8.32%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
-0.31%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
1.14%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
4.14%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.